1,133
Views
31
CrossRef citations to date
0
Altmetric
Research Article

A synthetic curcumin derivative hydrazinobenzoylcurcumin induces autophagy in A549 lung cancer cells

, , , &
Pages 111-116 | Received 26 Mar 2013, Accepted 16 Jun 2013, Published online: 18 Sep 2013

References

  • Acharya BR, Bhattacharyya S, Choudhury D, Chakrabarti G. (2011). The microtubule depolymerizing agent naphthazarin induces both apoptosis and autophagy in A549 lung cancer cells. Apoptosis 16:924–39
  • Alva AS, Gultekin SH, Baehrecke EH. (2004). Autophagy in human tumors: Cell survival or death? Cell Death Differ 11:1046–8
  • Aggarwal BB, Kumar A, Bharti AC. (2003). Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 23:363–98
  • Chen Y, Azad MB, Gibson SB. (2009). Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ 16:1040–52
  • Choi KS. (2012). Autophagy and cancer. Exp Mol Med 44:109–20
  • Faião-Flores F, Suarez JA, Maria-Engler SS, et al. (2013). The curcumin analog DM-1 induces apoptotic cell death in melanoma. Tumor Biol 34:1119–29
  • Gurusamy N, Das DK. (2009). Autophagy, redox signaling, and ventricular remodeling. Antioxid Redox Signal 11:1975–88
  • Kabeya Y, Mizushima N, Ueno T, et al. (2000). LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19:5720–8
  • Kabeya Y, Mizushima N, Yamamoto A, et al. (2004). LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci 117:2805–12
  • Kumaravel M, Sankar P, Rukkumani R. (2012). Antiproliferative effect of an analog of curcumin bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione in human breast cancer cells. Eur Rev Med Pharmacol Sci 16:1900–7
  • Lee J, Giordano S, Zhang JH. (2012). Mitochondria and oxidative stress: Cross-talk and redox signaling. Autophagy 441:523–40
  • Lee YJ, Kim NY, Suh YA, Lee C. (2011). Involvement of ROS in curcumin-induced autophagic cell death. Korean J Physiol Pharmacol 15:1–7
  • Le Grand JN, Chakrama FZ, Seguin-Py S, et al. (2011). GABARAPL1 antibodies: Target one protein, get one free! Autophagy 7:1098–107
  • Levine B. (2007). Cell biology: Autophagy and cancer. Nature 44:745–7
  • Liu B, Cheng Y, Zhang B, et al. (2009). Polygonatum cyrtonema lectin induces apoptosis and autophagy in human melanoma A375 cells through a mitochondria-mediated ROS–p38–p53 pathway. Cancer Lett 275:54–60
  • Liu Y, Shreder KR, Gai W, et al. (2005). Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase. Chem Biol 11:99–107
  • Munafo DB, Colombo MI. (2011). A novel assay to study autophagy: Regulation of autophagosome vacuole size by amino acid deprivation. J Cell Sci 114:3619–29
  • Mizushima N, Yoshimori T. (2007). How to interpret LC3 immuno-blotting. Autophagy 3:542–5
  • Shim JS, Kim DH, Jung HJ, et al. (2002). Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation. Bioorg Med Chem 10:2987–92
  • Tanida I, Ueno T, Kominami E. (2004). LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 36:2503–18
  • Wang Q, Liang B, Shirwany NA, Zou MH. (2011). 2-Deoxy-d-glucose treatment of endothelial cell induces autophagy by reactive oxygen species-mediated activation of the AMP-activated protein kinase. PLoS One 6:e17234 (1--12)
  • Wang Y, Zhou T, Sun HY, Huang B. (2012). Study on the relationship between autophagy and apoptosis in A549 cells induced by curcumin analogue EF24. Chin J Cell Biol 34:590–6
  • Xiao J, Wang Y, Peng J, et al. (2012). A synthetic compound, 1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one (B63), induces apoptosis and activates endoplasmic reticulum stress in non-small cell lung cancer cells. Inter J Cancer 131:1455–65
  • Zhou GZ, Jing HJ, Lu YK, et al. (2012). Establishment of the LC3 recombinant vector and its expression in prokaryotic and eukaryotic cells. Biotechnology 22:13–17. (in Chinese)
  • Zhang D, Fan D. (2007). Muhidrug resistance in gastric cancer: Recent research advances and ongoing therapeutic challenges. Expert Rev Anticancer Ther 7:1369–78

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.